KRONİK AKTİF HEPATÝT B'Lİ ÇOCUK HASTADA İNTERFERON VE LAMUVİDİN TEDAVİSİ: OLGU SUNUMU

Year 2002, Volume: 3 Issue: 3, 35 - 37, 01.12.2002

Ferah Sönmez Tolga Ünüvar Gülten İnan Münevver Türkmen Ali Öztürk Emel Dikicioğlu

Abstract

-

Keywords

Kronik hepatit B, INF alfa 2a, lamivudin, tedavi

Interferon and Lamivudine Combination Therapy in a Child with Chronic Hepatitis B: ACase Report

Abstract

As of today, there is yet no succesful treatment of chronic hepatitis B. Failure of interferon a-2a treatment for chronic viral hepatitis has prompted combination therapy. We present a 4 year old male infected with chronic hepatitis B in the replication phase who was treated with a combination of interferon a-2a and lamivudine therapy. Full remission was reached at the end of one year and this affect was still observed after one months of follow-up. So we believe that efficiency of this combination must be researched with controlled and extensive studies.

Keywords

Chronic hepatitis B, interferon -2a, lamivudine, combination therapy

References

• 1. Çakaloðlu Y, Ökten A. Kronik viral hepatitlerde tedavi yaklaþýmlarý 1998Ankara Bilimsel TýpYayýnevi Sayfa: 26-51.
• 2. Pessoa MG, Wright TL. Update on clinical trials in the treatment of hepatitis B. J Gastroenterol Hepatol 1999;14 Suppl: 6-11.
• 3. Schalm SW, Heathcote J, Cianciara J et al. Lamivudin and alpha interferon combination treatment of patients with chronic hepatitis B infection:a randomised trial. Gut 2000;46: 562-8.
• 4. Farrel G. Hepatitis B antigen seroconversion effects of lamivudine alone or in combination with interferon alpha. J Med Virol 2000;6: 374-9.
• 5. Mutimer D, Naoumov Nhonkoop P et al. Combination alpha-interferon and lamivudine therapy for alphainterferon-rezistant chronic hepatitis B infection: results of a pilot study. J.Hepatol 1998;28: 923-9.
• 6. Wong DKH, Cheung AM, O'Rourke K, et al. Effect of alpha interferon treatment in patients with hepatitis B antigen positive chronic hepatitis B. A meta analysis. Ann Intern Med 1993;119: 312-323.
• 7. Wong JB, Koff RS, Tine F, Pauker SG. Costeffectiveness of interferon-á 2b treatment for hepatitis B e antigen-positive chronic hepatitis B. Ann Intern Med 1995;122: 664-675.
• 8. Janssen HL, Gerken G, Carreno V et al. Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 1999;30: 238-43.
• 9. Lau DT, Everhart C, Kleiner DE et al. Long-term Follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology 1997; 113: 1660-7.
• 10. Rumi M, Romeo R, de Filippi F et al. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B. Ital J Gastroenterol 1993;2:117-20.
• 11. Dusheiko G, Lamivudine of chronic hepatitis B. Rev Med Virol 1998 ;8: 153-159.
• 12. Dienstag Jl,Schiff ER,Wright TL et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341: 1256-63.
• 13. Lai CL, Chien RN, Leung NW et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998; 339 : 61-8.